Open Access
Performance standards for antimicrobial susceptibility testing
Reads0
Chats0
TLDR
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards.Abstract:
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards: M02-A12—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition; M07-A10—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Tenth Edition; and M11-A8—Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard— Eighth Edition. The standards contain information about both disk (M02) and dilution (M07 and M11) test procedures for aerobic and anaerobic bacteria. Clinicians depend heavily on information from the microbiology laboratory for treatment of their seriously ill patients. The clinical importance of antimicrobial susceptibility test results demands that these tests be performed under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. The tabular information presented here represents the most current information for drug selection, interpretation, and QC using the procedures standardized in the most current editions of M02, M07, and M11. Users should replace the tables published earlier with these new tables. (Changes in the tables since the previous edition appear in boldface type.) Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI supplement M100S (ISBN 1-56238-923-8 [Print]; ISBN 1-56238924-6 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2016. The data in the interpretive tables in this supplement are valid only if the methodologies in M02-A12—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition; M07-A10—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Tenth Edition; and M11-A8—Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard— Eighth Edition are followed.read more
Citations
More filters
Journal ArticleDOI
Rapid detection of carbapenemase-producing Enterobacteriaceae.
TL;DR: To rapidly identify carbapenemase producers in Enterobacteriaceae, the Carba NP test was developed and was 100% sensitive and specific compared with molecular-based techniques.
Journal ArticleDOI
Prevalence in the United States of aac(6′)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme
TL;DR: Aac(6′)-Ib-cr was geographically widespread, stable over time, most common in Escherichia coli, equally prevalent in ciprofloxacin-susceptible and -resistant strains, and not associated with qnr genes.
Journal ArticleDOI
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections
TL;DR: Azithromycin is effective for the management of uncomplicated typhoid fever and may serve as an alternative oral drug in areas where fluoroquinolone resistance is common and ciprofloxacin susceptibility breakpoints were lowered to account for accumulating clinical, microbiologic, and pharmacokinetic-pharmacodynamic data.
Journal ArticleDOI
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
Jennifer H. Moffatt,Marina Harper,Marina Harper,Paul Harrison,John Df Hale,Evgeny Vinogradov,Torsten Seemann,Rebekah Henry,Bethany Crane,Frank St. Michael,Andrew D. Cox,Ben Adler,Ben Adler,Roger L. Nation,Jian Li,John D. Boyce,John D. Boyce +16 more
TL;DR: It is shown that A. baumannii can rapidly develop resistance to polymyxin antibiotics by complete loss of the initial binding target, the lipid A component of lipopolysaccharide (LPS), which has long been considered to be essential for the viability of Gram-negative bacteria.
Journal ArticleDOI
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.
Daniel B. Jernigan,Pratima L Raghunathan,Beth P. Bell,Ross J. Brechner,Eddy A. Bresnitz,Jay C. Butler,Marty Cetron,Mitch Cohen,Timothy J. Doyle,Marc Fischer,Carolyn M. Greene,Kevin S. Griffith,Jeannette Guarner,James L. Hadler,James A. Hayslett,Richard D. Meyer,Lyle R. Petersen,Michael R. Phillips,Robert W. Pinner,Tanja Popovic,Conrad P. Quinn,Jennita Reefhuis,Dori B. Reissman,Nancy E. Rosenstein,Anne Schuchat,Wun-Ju Shieh,Larry Siegal,David L. Swerdlow,Fred C. Tenover,Marc S. Traeger,John W. Ward,Isaac B. Weisfuse,Steven T. Wiersma,Kevin Yeskey,Sherif R. Zaki,David A. Ashford,Bradley A. Perkins,Steve Ostroff,James M. Hughes,David W. Fleming,Jeffrey P. Koplan,Julie L. Gerberding +41 more
TL;DR: A national investigation was initiated to identify additional cases and determine possible exposures to Bacillus anthracis, and 22 cases of anthrax were identified; 5 of the inhalational cases were fatal.